Heat Biologics' Series B Round

Heat Biologics raised a round of funding on April 09, 2013.

Heat Biologics is a clinical-stage company focused on developing its off-the-shelf ImPACT therapeutic vaccines to combat a wide range of cancers and infectious diseases. ImPACT Therapy exploits the na…

Articles about Heat Biologics' Series B Round: